The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
| Title |
Olanzapine in long‐term treatment for bipolar disorder
|
|---|---|
| Published in |
Cochrane database of systematic reviews, January 2009
|
| DOI | 10.1002/14651858.cd004367.pub2 |
| Pubmed ID | |
| Authors |
Andrea Cipriani, Jennifer M Rendell, John Geddes |
| Abstract |
Many patients with bipolar disorder require long-term treatment to prevent recurrence. Antipsychotic drugs are often used to treat acute manic episodes. It is important to clarify whether olanzapine could have a role in long-term prevention of manic and depressive relapses. |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 243 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Netherlands | 1 | <1% |
| Australia | 1 | <1% |
| Brazil | 1 | <1% |
| India | 1 | <1% |
| Canada | 1 | <1% |
| Spain | 1 | <1% |
| Unknown | 237 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 33 | 14% |
| Student > Bachelor | 28 | 12% |
| Student > Master | 26 | 11% |
| Student > Doctoral Student | 15 | 6% |
| Student > Ph. D. Student | 14 | 6% |
| Other | 48 | 20% |
| Unknown | 79 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 79 | 33% |
| Psychology | 27 | 11% |
| Pharmacology, Toxicology and Pharmaceutical Science | 12 | 5% |
| Nursing and Health Professions | 11 | 5% |
| Neuroscience | 6 | 2% |
| Other | 28 | 12% |
| Unknown | 80 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 March 2024.
All research outputs
#7,702,129
of 26,322,284 outputs
Outputs from Cochrane database of systematic reviews
#9,002
of 13,211 outputs
Outputs of similar age
#47,039
of 190,071 outputs
Outputs of similar age from Cochrane database of systematic reviews
#40
of 84 outputs
Altmetric has tracked 26,322,284 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 13,211 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.6. This one is in the 30th percentile – i.e., 30% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 190,071 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 84 others from the same source and published within six weeks on either side of this one. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.